Abstract-Impaired insulin signaling via phosphatidylinositol 3-kinase/Akt to endothelial nitric oxide synthase (eNOS) in the vasculature has been postulated to lead to arterial dysfunction and hypertension in obesity and other insulin resistant states. To investigate this, we compared insulin signaling in the vasculature, endothelial function, and systemic blood pressure in mice fed a high-fat (HF) diet to mice with genetic ablation of insulin receptors in all vascular tissues (TTr-IR Ϫ/Ϫ ) or mice with genetic ablation of Akt1 (Akt1Ϫ/Ϫ). HF mice developed obesity, impaired glucose tolerance, and elevated free fatty acids that was associated with endothelial dysfunction and hypertension. Basal and insulin-mediated phosphorylation of extracellular signal-regulated kinase 1/2 and Akt in the vasculature was preserved, but basal and insulin-stimulated eNOS phosphorylation was abolished in vessels from HF versus lean mice. In contrast, basal vascular eNOS phosphorylation, endothelial function, and blood pressure were normal despite absent insulinmediated eNOS phosphorylation in TTr-IR Ϫ/Ϫ mice and absent insulin-mediated eNOS phosphorylation via Akt1 in Akt1Ϫ/Ϫ mice. In cultured endothelial cells, 6 hours of incubation with palmitate attenuated basal and insulinstimulated eNOS phosphorylation and NO production despite normal activation of extracellular signal-regulated kinase 1/2 and Akt. Moreover, incubation of isolated arteries with palmitate impaired endothelium-dependent but not vascular smooth muscle function. Collectively, these results indicate that lower arterial eNOS phosphorylation, hypertension, and vascular dysfunction following HF feeding do not result from defective upstream signaling via Akt, but from free fatty acid-mediated impairment of eNOS phosphorylation. Key Words: arterial insulin signaling Ⅲ hypertension Ⅲ endothelial dysfunction Ⅲ mice Ⅲ diabetes S timulation of insulin receptors in the vasculature leads to increased activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and the mitogen-activated protein (MAP) kinase (eg, extracellular signaling-regulated kinase [ERK]1/2) pathway. [1][2][3][4] Insulin receptor (IR)-mediated stimulation of PI3K/Akt leads to endothelial nitric oxide (NO) synthase (eNOS) phosphorylation, NO production, and vasorelaxation. 4 -7 Insulin-mediated activation of ERK1/2 leads to endothelin (ET)-1 production, inhibition of eNOS phosphorylation, and subsequent vasocontraction. 1,4,8 Evidence from several experimental models of insulin resistance reveals impaired insulin-mediated PI3K/Aktdependent signaling in the vasculature, whereas ERK1/2 pathways are preserved or even augmented. 2,8,9 Collectively, these observations have led to the hypothesis that an imbalance in vascular insulin-mediated signaling can precipitate cardiovascular complications including endothelial dysfunction and hypertension. 1,4 Recently, it was shown that insulinmediated Akt phosphorylation was preserved, but NOmediated vasorelaxation was blunted, in arteries from obese, glucose intolerant versus lean mice, suggesting that impaired insulin-mediated signaling to eNOS via Akt might not be required to reduce NO bioavailability to an extent that produces endothelial dysfunction. 10 Cardiovascular consequences of decreased insulinmediated signaling have been evaluated in mice homozygous for IR deletion in the endothelium (VENIRKO mice) 3 and in heterozygous mice with germline IR deletion (heterozygous IRKO mice). 11 Vascular eNOS and ET-1 mRNA were lower in VENIRKO versus wild-type (WT) mice, blood pressure was similar between groups, but eNOS protein and phosphorylation levels were not reported. In contrast, eNOS mRNA was unchanged, blood pressure was elevated, and insulinmediated eNOS phosphorylation in the vasculature and indi- Original received October 29, 2007; resubmission received October 15, 2008; revised resubmission received February 18, 2009; accepted March 19, 2009. Thus, the specific contribution from impaired vascular insulin-mediated signaling to the pathogenesis of arterial dysfunction and hypertension is unclear.
S
timulation of insulin receptors in the vasculature leads to increased activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and the mitogen-activated protein (MAP) kinase (eg, extracellular signaling-regulated kinase [ERK]1/2) pathway. [1] [2] [3] [4] Insulin receptor (IR)-mediated stimulation of PI3K/Akt leads to endothelial nitric oxide (NO) synthase (eNOS) phosphorylation, NO production, and vasorelaxation. 4 -7 Insulin-mediated activation of ERK1/2 leads to endothelin (ET)-1 production, inhibition of eNOS phosphorylation, and subsequent vasocontraction. 1, 4, 8 Evidence from several experimental models of insulin resistance reveals impaired insulin-mediated PI3K/Aktdependent signaling in the vasculature, whereas ERK1/2 pathways are preserved or even augmented. 2, 8, 9 Collectively, these observations have led to the hypothesis that an imbalance in vascular insulin-mediated signaling can precipitate cardiovascular complications including endothelial dysfunction and hypertension. 1, 4 Recently, it was shown that insulinmediated Akt phosphorylation was preserved, but NOmediated vasorelaxation was blunted, in arteries from obese, glucose intolerant versus lean mice, suggesting that impaired insulin-mediated signaling to eNOS via Akt might not be required to reduce NO bioavailability to an extent that produces endothelial dysfunction. 10 Cardiovascular consequences of decreased insulinmediated signaling have been evaluated in mice homozygous for IR deletion in the endothelium (VENIRKO mice) 3 and in heterozygous mice with germline IR deletion (heterozygous IRKO mice). 11 Vascular eNOS and ET-1 mRNA were lower in VENIRKO versus wild-type (WT) mice, blood pressure was similar between groups, but eNOS protein and phosphorylation levels were not reported. In contrast, eNOS mRNA was unchanged, blood pressure was elevated, and insulinmediated eNOS phosphorylation in the vasculature and indi-ces of NO bioavailability were reduced in heterozygous IRKO versus WT animals. Heterozygous IRKO mice are glucose-intolerant and hyperinsulinemic, which may secondarily influence vascular function. 11, 12 Thus, the specific contribution from impaired vascular insulin-mediated signaling to the pathogenesis of arterial dysfunction and hypertension is unclear.
In light of the uncertainty concerning the cardiovascular consequence(s) of insulin resistance in the vasculature, we compared insulin-mediated signal transduction to eNOS in the vasculature, endothelial function, and blood pressure between mice that consumed high-fat (HF) and standard chow (CON). Our findings indicated that endothelial dysfunction and hypertension associated with diet-induced obesity could not be explained by defective upstream signaling via Akt to eNOS in the vasculature. To validate these observations, we used 2 genetic models of "insulin resistance" that lack systemic metabolic disturbances associated with obesity and type 2 diabetes. First, IR-null mice with transgenic reexpression of the IR in brain, liver, and pancreatic ␤-cells (TTr-IR Ϫ/Ϫ mice) 13 were used to test the consequence of absent insulin-mediated signaling to eNOS on vascular function and blood pressure. Second, Akt1-null mice (Akt1Ϫ/Ϫ mice) 14, 15 were used to evaluate the contribution of insulin-mediated signaling via Akt1 to eNOS on vascular function and blood pressure. Akt1Ϫ/Ϫ mice were chosen because this isoform was recently shown to be most important in regulating eNOS, based on observations that basal and vascular endothelial cell growth factor (VEGF)-stimulated NO production were reduced in endothelial cells isolated from mice with deletion of Akt1 but not Akt2. 16 Findings from these genetic models suggested that disruption of insulin or Akt1 signaling to eNOS in the vasculature does not precipitate endothelial dysfunction or hypertension. Because the cardiovascular complications observed in mice with diet-induced obesity might not result from impaired vascular insulin-mediated signal transduction, we sought to determine the role of elevated circulating free fatty acids (FFAs). 17, 18 When bovine aortic endothelial cells (BAECs) were incubated with the saturated FFA palmitate, both basal and insulin-mediated eNOS phosphorylation and NO production were impaired despite normal activation of Akt and ERK. Furthermore, palmitate incubation precipitated endothelium-dependent dysfunction in isolated vessels. Collectively, these results indicate that reduced arterial eNOS phosphorylation and vascular complications do not result from defective upstream signaling via Akt but might be secondary to FFA-mediated impairment of eNOS phosphorylation.
Materials and Methods
All protocols were approved by the Institutional Animal Care and Use Committee. Ten-week-old C57Bl6 mice that consumed standard (CON) or HF chow for 10 to 12 weeks were used for experiments on metabolic characterization, insulin-mediated signal transduction in the vasculature, blood pressure, vascular function, detection of vascular oxidant load, and mRNA expression. Similar experiments were completed in TTr-IR Ϫ/Ϫ 13,19,20 mice, Akt1Ϫ/Ϫ 14 mice, and their WT littermates. Detailed procedures are provided in the expanded Materials and Methods section in the online data supplement at http://circres.ahajournals.org.
Statistics
Data are presented as meansϮSEM. Significance was accepted at PϽ0.05. Comparison of 1 time point between 2 groups was made using an unpaired t test. Comparison of multiple time points between groups was made using a 1-way or 2-way repeated measures ANOVA. Tukey post hoc tests were performed when significant main effects were obtained.
Results

Metabolic Characterization
HF and CON Mice
Body weight increased (41% versus 18%; Figure 1A ), gonadal fat pad mass was greater (0.91Ϯ0.25 versus 0.35Ϯ0.08 g), and fasting glucose (122Ϯ9 versus 107Ϯ7 mg/dL), area under the glucose tolerance test (GTT) curve (42397Ϯ3064 versus 28178Ϯ1507; Figure 1B ), insulin ( Figure 1C ), and FFAs were higher ( Figure 1D ) in HF versus CON mice, respectively. Dual energy X-ray absorption indicated increased body and fat mass and decreased lean mass in HF versus CON mice, respectively ( Figure I in the online data supplement). Dihydroethidium staining 21 revealed no differences in superoxide anion (O 2 Ϫ ) production (relative fluorescence intensity [RFI] units) in the endothelium (1438Ϯ182 and 1255Ϯ124) or vascular smooth muscle (904Ϯ89 and 814Ϯ143) of HF and CON mice, respectively (nϭ5 per group). Vascular NADPH oxidase activity was similar between HF and CON mice (not shown). The fold change in eNOS (0.99Ϯ0.19) and ET-1 mRNA (1.41Ϯ0.14; Pϭ0.08) in HF relative to WT mice was not different (nϭ5 per group). Figure  2C ) were similar between WT and TTr-IR Ϫ/Ϫ mice, respectively. Insulin was greater in both the fasting condition (ie, minute 0) and 30 minutes following IP glucose during the GTT in TTr-IR Ϫ/Ϫ mice ( Figure 2D ). Vascular dihydroethidium staining was similar between TTr-IR Ϫ/Ϫ and WT mice in the endothelium (1334Ϯ97 and 1538Ϯ88) and vascular smooth muscle (876Ϯ26 versus 1025Ϯ45; nϭ5 per group), respectively. The fold change in eNOS (0.98Ϯ0.28) and ET-1 (1.06Ϯ0.16) mRNA relative to WT mice was not different between groups (nϭ5 per group).
TTr-IR
Because metabolic disturbances and vascular complications (see below) were observed in HF but not TTr-IR Ϫ/Ϫ mice, we placed TTr-IR Ϫ/Ϫ mice on HF chow (HF-TTr-IR Ϫ/Ϫ mice). However, HF-TTr-IR Ϫ/Ϫ mice did not develop systemic metabolic disturbances (Online Figure III , A through D) or arterial dysfunction (data not shown). As such, no further experiments were performed on these animals. Akt1Ϫ/Ϫ mice have a metabolic profile similar to their WT littermates. 14, 15 
Vascular Signal Transduction
HF and CON Mice
Compared to vehicle, insulin increased the ratio of phosphorylated (p)-ERK1/2 to total ERK similarly in aortae from CON and HF mice ( Figure 3A) . Insulin increased the ratio of p-Akt S473 and p-Akt T308 to total Akt in CON and HF animals, but insulin-mediated Akt phosphorylation at both residues was modestly yet significantly blunted in arteries from HF versus CON mice ( Figure 3B ). Furthermore, insulin increased the ratio of p-eNOS S1177 to total eNOS in arteries from CON but not HF mice ( Figure 3C ). Importantly, basal levels of p-eNOS S1177 were virtually nonexistent in arteries from HF versus CON mice, and insulin was not capable of increasing p-eNOS at this site. HF feeding did not alter vascular eNOS at T495, S617, or S635, or the upstream 
Symons et al Insulin and Akt Regulation of Blood Pressure
kinases AMP-activated protein kinase (AMPK) or protein kinase (PK)A (Online Table I ).
TTr-IR
؊/؊ and WT Mice Compared to vehicle stimulation, insulin increased the ratio of p-ERK1/2 to total ERK ( Figure 4A ), p-Akt S473 or p-Akt T308 to total Akt ( Figure 4B ), and p-eNOS S1177 to total eNOS in aortae from WT mice ( Figure 4C ). As expected, these effects were not observed in arteries from TTr-IR Ϫ/Ϫ animals.
Akt1؊/؊ and WT Mice
Western blot experiments confirmed the absence of Akt1 protein in the vasculature of Akt1Ϫ/Ϫ mice (Online Figure  II, B) . In aortae from WT and Akt1Ϫ/Ϫ mice, insulin equivalently increased the ratio of p-ERK1/2 to total ERK1/2 ( Figure 5A ), p-Akt S473 or p-Akt T308 to total Akt ( Figure  5B ), and p-eNOS S1177 to total eNOS ( Figure 5C ). To explore whether insulin-mediated Akt phosphorylation in vessels from Akt1Ϫ/Ϫ mice was mediated via the Akt2 isoform, Akt2 was immunoprecipitated from vascular homogenates obtained from Akt1Ϫ/Ϫ and WT mice after stimulation with insulin or vehicle. Compared to vehicle, insulin increased the ratio of p-Akt S473 and p-Akt T308 to total Akt2 in both groups ( Figure 5D ). These results confirm insulin-mediated p-Akt in Akt1Ϫ/Ϫ mice is mediated via the Akt2 isoform. Additionally, we sought to confirm the compartment wherein eNOS phosphorylation was occurring. Results in Online Figure IV show that insulin-stimulation evokes a robust increase in p-eNOS to total eNOS in intact arteries that is abolished in vessels denuded of endothelium. The pattern of insulin-mediated signaling for ERK, Akt, and eNOS among the 3 groups (ie, HF, TTr-IR Ϫ/Ϫ , and Akt1Ϫ/Ϫ mice and their respective controls) was similar between aorta and homogenates of iliac/femoral arteries.
Blood Pressure
Arterial blood pressure and heart rate were assessed in conscious mice for 30 seconds every 15 minutes over 72 hours starting 6 days following surgical implantation of a telemetry device in the abdomen. Blood pressure was greater , and p-eNOS S1177 (C) in aortae from CON mice. Insulin-stimulated p-ERK was intact in aorta from HF mice, but insulinstimulated p-Akt S473/T308 was blunted, and insulin-stimulated p-eNOS S1177 was abolished. Basal p-eNOS S1177 was minimal in aorta from HF vs CON mice. Immunoblots (top) and densitometric measurements (bottom) of p-protein to total protein (arbitrary units) from aortae of 7 to 9 mice per group are shown. *PϽ0.05 (ϩ) vs (Ϫ); **PϽ0.05 HF vs CON. in HF versus CON mice ( Figure 6A ), but heart rate (646Ϯ45 versus 601Ϯ18 bpm, respectively) was similar between groups. Mean arterial pressure ( Figure 6B ) and heart rate (608Ϯ21 and 636Ϯ12 bpm) were similar between TTr-IR Ϫ/Ϫ and WT mice, respectively. Likewise, arterial pressure (Figure 6C ) and heart rate were similar between Akt1Ϫ/Ϫ (646Ϯ16 bpm) and WT mice (620Ϯ26).
Vascular Function
Because basal vascular eNOS phosphorylation was compromised, and hypertension existed, in HF but not TTr-IR Ϫ/Ϫ or Akt1Ϫ/Ϫ mice, we sought to determine whether functional indices of stimulated and basal eNOS activity displayed a similar pattern. Acetylcholine-evoked ( Figure 7A Online Table II .
Treatment of BAECs and Arteries With Palmitate
Arterial dysfunction existed in HF mice, yet insulin-mediated signal transduction to eNOS via Akt1 in the vasculature was intact. Thus, we sought to determine whether a component of the systemic environment ie, elevated FFAs, was responsible for arterial dysfunction and lower basal and insulin-stimulated p-eNOS S1177 to total eNOS in the vasculature of HF versus CON mice. First, BAECs treated with 500 mol/L palmitate for 6 hours had lower basal and insulin-stimulated p-eNOS S1177, yet signaling to Akt and ERK was intact ( Figure 8A through 8C). Second, 6 hours of palmitate treatment abolished insulin-mediated NO production by BAECs ( Figure  8D ). Finally, 3 hours of palmitate treatment impaired endothelium-dependent ( Figure 8E ) but not endotheliumindependent vasorelaxation (not shown). In parallel experiments, neither endothelium-dependent nor endothelium-independent vasorelaxation was impaired in arteries treated for 3 hours with vehicle (BSA) or volume (milliQ water; data not shown). Basal p-eNOS was lowered to the same degree by 3 , and p-eNOS S1177 (C) equivalently in aortae from Akt1Ϫ/Ϫ and WT mice (nϭ7 to 9 per group). *PϽ0.05 (ϩ) vs (Ϫ). To explore whether insulin-mediated Akt phosphorylation in vessels from Akt1Ϫ/Ϫ mice was mediated via the Akt2 isoform, Akt2 was immunoprecipitated (IP) from vascular homogenates obtained from Akt1Ϫ/Ϫ and WT mice after stimulation with insulin or vehicle, and immunoblotted (IB) with phospho-specific antibodies (D). Compared to vehicle (Ϫ), insulin (ϩ) increased the ratio of p-Akt S473 and p-Akt T308 to total Akt2 in both groups (nϭ4 mice per group).
hours ( Figure 8F ) and 6 hours (data not shown) of palmitate incubation.
Discussion
We assessed the contribution from vascular insulin signaling to eNOS in regulating endothelial function and blood pressure in mice with diet-induced obesity and in mice with complete (ie, TTr-IR Ϫ/Ϫ mice) and selective (ie, Akt1Ϫ/Ϫ mice) "resistance" to insulin signaling. Five main findings were observed. First, in HF mice, insulin-stimulated phosphorylation of eNOS was abolished, hypertension existed, but insulin-mediated signaling in the vasculature to ERK1/2 and Akt was preserved. Second, in TTr-IR Ϫ/Ϫ mice, insulinstimulated phosphorylation of ERK1/2, Akt, and eNOS in the vasculature was predictably absent, but arterial blood pressure was similar to WT littermates. Third, the absence of Akt1 expression did not influence insulin-mediated phosphorylation of ERK1/2, Akt, and eNOS in the vasculature or blood pressure. Fourth, basal eNOS phosphorylation was almost absent in the vasculature of HF mice, and these animals displayed endothelial dysfunction together with systemic disturbances associated with diet-induced obesity. In contrast, basal eNOS phosphorylation, vascular function, and metabolic characteristics were similar among TTr-IR Ϫ/Ϫ and Akt1Ϫ/Ϫ animals and their respective WT littermates. These results suggested that hypertension and vascular dysfunction in mice with diet-induced obesity might be precipitated by reduced basal vascular eNOS phosphorylation caused by a component(s) of the circulating metabolic environment rather than by defective signaling via Akt1 to eNOS. The component we focused on was the elevation in FFAs observed in obese versus lean mice. In this regard, our fifth main finding was that basal and insulin-mediated eNOS phosphorylation and NO bioavailability are impaired, but signaling to Akt and ERK are intact, in endothelial cells incubated with the saturated FFA palmitate. Thus, elevated FFAs might be responsible for lowering vascular eNOS to a degree that precipitates cardiovascular complications in mice with dietinduced obesity.
Although impaired insulin signaling in the vasculature is widely accepted to be associated with obesity, type 2 diabetes, and generalized insulin resistance, 1 the specific contribution of vascular insulin-resistance to the pathogenesis of arterial dysfunction and hypertension has not been definitively proven. For example, insulin resistance in spontaneously hypertensive rats (SHR) was accompanied by impaired vascular PI3K-dependent NO production, enhanced mitogenactivated protein kinase (MAPK)-dependent ET-1 secretion, and endothelial dysfunction versus control (WKY) rats. 8 In that report, mesenteric arterial function was restored in SHRs by ET-1A/B receptor blockade or by MAPK/ERK kinase inhibition. Whereas this study and others 2, 9 suggest that an imbalance in vascular insulin-mediated signaling via Akt to eNOS together with intact or exaggerated MAPK-dependent ET-1 production has the potential to disrupt vascular homeostasis, a recent publication challenged this concept. Specifically, insulin-stimulated Akt phosphorylation was normal in arteries from mice with diet-induced obesity and glucose intolerance, although eNOS structure was disrupted and endothelial dysfunction was present. 10 These results suggest that a component of endothelial dysfunction might be independent of upstream modulation via Akt.
The contribution of insulin-mediated signal transduction in the vasculature to blood pressure regulation is also unclear. For instance, blood pressure measured via tail cuff was similar between VENIRKO and WT mice, 3 whereas hypertension existed in IRS-1-deficient (IRS-1 Ϫ/Ϫ ) mice versus their respective controls. 22 Because VENIRKO mice model nonselective insulin resistance and IRS-1 Ϫ/Ϫ mice model PI3K/Akt selective "resistance" to IR-mediated signaling, these findings support the hypothesis that imbalanced downstream signaling from the IR disrupts cardiovascular homeostasis. 1, 4, 23, 24 In contrast, arterial pressures were higher in mice wherein both signaling pathways downstream from the IR were thought to be compromised (ie, heterozygous IRKO mice) in a balanced manner. 11 In an attempt to clarify this issue, we compared insulin signaling in the vasculature, endothelial function, and systemic blood pressure in mice with diet-induced obesity to mice with genetic ablation of insulin receptors in all vascular tissues (TTr-IR Ϫ/Ϫ ) or mice with genetic ablation of Akt1 (Akt1Ϫ/Ϫ). We hypothesized that HF feeding would selectively impair insulin-mediated signaling to eNOS via Akt in the vasculature, and this defect would lead to hypertension and endothelial dysfunction. Our results did not support this hypothesis. Instead, relative to arteries from lean mice, insulin-mediated Akt phosphorylation was preserved but insulin-stimulated eNOS phosphorylation at S1177 was abolished in vessels from obese animals. Furthermore, hypertension and endothelial dysfunction existed in obese versus lean mice. These data indicate the lack of insulin-mediated eNOS phosphorylation at S1177 in the vasculature, systemic hypertension, and vascular dysfunction that existed in HF mice did not result from deficient upstream activation of eNOS via Akt.
In addition to diet-induced obesity produced by HF feeding, we used 2 genetic models to test our overall hypothesis. First, we reasoned that if insulin-mediated signal transduction was absent, ie, using TTr-IR Ϫ/Ϫ mice, then there likely would be no net effect on blood pressure. Our findings support this hypothesis and confirm a previous study wherein similar blood pressures existed between VENIRKO and WT mice 3 but contrast with results indicating that heterozygous IRKO mice are hypertensive relative to their WT littermates. 11 In this latter study, vascular insulin-mediated eNOS phosphorylation was attenuated in aortae from heterozygous IRKO versus WT mice. Although these data suggest the heterozygous IRKO phenotype might have resulted from impaired insulin signaling to eNOS, upstream kinases responsible for activating this enzyme were not evaluated. As such, it is not possible to know whether an imbalance in insulin-mediated signal transduction existed in vessels from heterozygous IRKO versus WT mice.
Mice with targeted deletion of Akt1 were used as a second approach to test our overall hypothesis. We reasoned that if selective resistance to insulin-stimulated eNOS phosphorylation via Akt in the vasculature contributed to hypertension, then blood pressure should be elevated in Akt1Ϫ/Ϫ versus WT mice. Mice with specific deletion of Akt1 were chosen for several reasons. First, of the 3 major Akt isoforms (Akt1/PKB␣, Akt2/PKB␤, and Akt3/PKB␥), only Akt1 and Akt2 are present in aortae and femoral arteries of mice. 16 Second, evidence from mouse lung endothelial cells indicates that Akt1 is the isoform predominantly responsible for basal and VEGF-stimulated NO production. 16 Finally, because Akt1 mice do not possess a diabetic phenotype, 14, 15 contributions from circulating metabolic factors to endothelial dysfunction or hypertension do not exist. Contrary to our hypothesis, blood pressures were not different between Akt1Ϫ/Ϫ and WT mice. Surprisingly, insulin-mediated Akt and eNOS phosphorylation were intact in both groups. Because Akt1 protein was verified to be absent in the same vessels wherein these results were obtained, we explored the possibility and confirmed experimentally that insulinmediated eNOS S1177 phosphorylation in the vasculature can occur via the Akt2 isoform. Whereas we observed robust insulin-mediated eNOS S1177 phosphorylation in vessels from Akt1Ϫ/Ϫ and WT mice, Ackah et al showed that VEGF-stimulated NO production was impaired in mouse lung endothelial cells obtained from Akt1Ϫ/Ϫ versus WT mice. 16 Our studies suggest that in endothelial cells and the vasculature, insulin and VEGF differ importantly in their ability to phosphorylate eNOS S1177 via Akt2. In our study and that of Ackah et al, the presence of Akt2 in endothelial cells of Akt1Ϫ/Ϫ mice was confirmed. Thus, whereas VEGF does not stimulate eNOS phosphorylation in the absence of Akt1 via residual Akt2 in mouse lung endothelial cells, we clearly show that insulin-mediated activation of Akt2 is sufficient to activate eNOS in the vasculature. We do not know the molecular basis for these differences, but spatial differences in the subcellular localization of Akt1 versus Akt2 and components of the VEGF or insulin signaling pathways might play a role. We also considered the possibility that differences arose from the fact that we studied signaling in whole artery homogenates versus cultured endothelial cells, because vascular compartments other than the endothelium might have contributed to the eNOS phosphorylation we observed. We believe this is unlikely, however, because insulin-mediated eNOS S1177 phosphorylation in intact vessels was abolished in arteries denuded of their endothelium (Online Figure IV) . Thus, the discrepancy between studies likely resides in differences in the signal transduction mechanisms for VEGF versus insulin.
Basal eNOS phosphorylation was virtually absent in vessels from HF versus control mice, whereas it was similar between TTr-IR Ϫ/Ϫ and Akt1Ϫ/Ϫ animals and their respective controls. Because phosphorylation of eNOS S1177 positively regulates eNOS activity, 5, [25] [26] [27] it is reasonable that NO bioavailability might have been compromised in vessels from HF mice to an extent that precipitated endothelial dysfunction and hypertension relative to TTr-IR Ϫ/Ϫ or Akt1Ϫ/Ϫ animals. This is supported by results from 3 protocols using isolated vessels. First, tension development in response to eNOS inhibition (a functional estimate of basal eNOS activity 28 ) was less in aortae and femoral arteries from HF versus control mice. Second, phenylephrine-induced responses were greater in HF mice, suggesting that endogenous opposition to vasocontraction from NO might be compromised. Finally, acetylcholine-evoked vasorelaxation (a functional estimate of stimulated eNOS activity) was blunted in vessels from HF versus control mice. Because these end points were generally similar between TTr-IR Ϫ/Ϫ and Akt1Ϫ/Ϫ mice and their WT littermates, it is reasonable to speculate that minimal basal eNOS phosphorylation at S1177 observed in vessels from HF mice might have precipitated endothelial dysfunction and hypertension. Collectively, the lack of basal arterial eNOS phosphorylation at S1177, rather than deficient signaling to eNOS via Akt1 in the vasculature, appears to contribute importantly to hypertension that exists in mice with dietinduced obesity. Further evidence supporting this statement is that p-eNOS S617 (another eNOS phosphorylation target downstream from Akt) was similar in vessels from CON and HF mice. In this regard, if defective signaling via Akt to eNOS contributed to minimal p-eNOS S1177, then p-eNOS S617 likely would have been lower.
Findings from studies similar to ours implicate hyperglycemia, defective signaling to eNOS via AMPK, and elevated FFAs as important contributors to impaired arterial eNOS activity, function, and/or phosphorylation. 10, 29, 30 Hyperglycemia in our HF mice was much less severe than values reported by Molnar et al, which might have contributed to increased oxidative stress and disruption of eNOS protein dimers in the vasculature. 10 Whereas Wu et al 29 demonstrated lower arterial p-AMPK T172 to total AMPK and impaired p-eNOS S1177 to total eNOS in arteries from fat-fed versus lean mice and in cultured cells treated with saturated versus unsaturated fatty acids, we found no difference in arterial p-AMPK between vessels from HF and CON animals. Du et al reported that reduced aortic eNOS activity in mice fed high-fat chow could be normalized by treatment with an antilipolytic agent that decreased fatty acid release from adipose cells. 30 Moreover, Edirisinghe et al observed impaired endothelial function in aortic segments incubated with palmitate for 60 minutes. 17 Because we observed a Ͼ3-fold elevation of FFAs in HF versus CON mice, we explored this mechanism further. When BAECs were incubated with palmitate, basal and insulin-stimulated eNOS phosphorylation was impaired, but signaling to ERK and Akt was intact. The palmitate-induced reduction of eNOS phosphorylation was sufficient to impair insulin-mediated NO production by BAECs and endothelium-dependent but not vascular smooth muscle function of isolated arteries. Results in BAECs and vessels exposed to palmitate mimic those we observed in arteries from HF mice. Because the source of fat in the HF diet primarily was from lard, it is possible that metabolites of saturated fatty acids (eg, the sphingolipid ceramide) might accumulate in response to HF feeding and lower arterial NO bioavailability. 29 Indeed, preliminary data from our laboratory indicate vascular ceramide increases Ϸ2-fold (PϽ0.05) in mice exposed to HF feeding for 10 to 14 weeks. Although further work is warranted to elucidate the precise molecular signal(s) whereby HF feeding precipitates hypertension and vascular dysfunction, results from the present study indicate these cardiovascular complications occur via mechanisms that are independent of defective IR-mediated signaling to eNOS via Akt1 in the vasculature and might be related to the accumulation of FFAs and subsequent impairment of vascular NO production. 
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Materials and Methods
All protocols were approved by the Institutional Animal Care and Use Committee of the University of Utah. Mice were maintained in a temperature-controlled barrier facility with a 12-hour light/dark cycle and were given free access to food and water. 10-week old C57Bl6 mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and Signal transduction in intact and denuded vessels. 3.8 mU insulin / g body weight was administered intravenously to 10 conscious mice. Five-min later, animals were anesthetized, the chest was opened, and the entire aorta was excised. After sectioning the aorta into two segments, each was opened longitudinally. One segment was denuded of endothelium (-endothelium) using a modified cotton-tipped applicator, while the other was left intact (+ endothelium). Each segment was snap frozen in liquid nitrogen, and later sonicated, centrifuged, and aliquoted for subsequent protein and immunoblotting analyses. Identical procedures were performed in 10 mice that were administered vehicle (saline) intravenously. Therefore, four groups of vessels (n=10 each) were studied i.e., insulin-treated (+ and -endothelium) and vehicle-treated (+ and -endothelium). Immunoblot analyses of p-eNOS S1177 and total eNOS were performed as described earlier.
Vascular function-TTr-IR
-/-, Akt1-/-, HF mice. Mice were anesthetized with 2-5% isoflurane. After opening the chest, segments of thoracic aorta were obtained just proximal to the bifurcation of the iliac arteries. Femoral arteries were isolated distal to the bifurcation of the internal iliac artery. During dissection, tissues were bathed in icecold, oxygenated NPSS. Once isolated and free of adherent tissue, arteries were mounted on a wire-type myograph while immersed in a temperature-controlled, 8 ml tissue bath containing NPSS. After the arteries were mounted, the tissue bath was warmed gradually to 37° C over 30-min with vessels at 0 mg tension. Throughout each experiment, pH and temperature of all buffer solutions were checked at 20-30-min intervals, and contents of the tissue bath were exchanged at 15-min intervals.
Experimental protocols specific to each vessel type are described.
Aortae. When the tissue bath reached 37°C, tension on aortae was increased manually over 60 min to 1500 mg (i.e., 375 mg every 15-min). Final tensions did not differ among groups. Thirty-min later, receptor-mediated vasocontractile responses to phenylephrine (PE, 10 -8 -10 -5 M) and potassium chloride (KCl, 10-100 mM) were assessed. Next, after arteries were precontracted to 65% of maximal PE-induced contraction and tension was stable, responses to: acetylcholine (ACh, 10 -8 -10 -4 M; to determine endotheliumdependent vasorelaxation); insulin (50 -5000 mU / ml); sodium nitroprusside (SNP, 10 -9 -10 -4 M; to determine endothelium-independent vasorelaxation); and N G monomethyl-Larginine (L-NMMA, 10 -3 M; to estimate basal nitric oxide production) 6 were performed.
Each experimental protocol was separated by at least 30-min.
Femoral arteries. When the tissue bath reached 37°C, tension on femoral arteries was increased manually over 8-min to 200 mg (i.e., 50 mg every 2-min). Final tensions did not differ among groups (Online Table II ). Thirty-min later, a series of internal circumference-active tension curves was constructed to determine the vessel diameter that evoked the greatest tension development (L max ) to 100 mM KCl. L max tension did not differ among groups. The same protocols as described earlier for aortae were completed. For aortae and femoral arteries, two vessel segments per mouse were treated identically and the results were averaged. All tension data were recorded continuously by a computer through an analog-to-digital interface card (Biopac Systems Inc., Santa Barbara, CA) that allowed for subsequent off-line quantitative analyses.
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Vascular function -acute palmitate incubation. Femoral arteries were obtained from 20-week old C57Bl6 mice to assess the effects of the saturated fatty acid palmitate (C16:0) on arterial function. Palmitate was used because it is the most physiologically abundant FFA. Mice were anesthetized and vessels were obtained and mounted as described. After determining L max , performing a PE dose-response curve, and assessing endothelium-dependent vasorelaxation using acetylcholine, vessels were incubated with 500 uM palmitate, vehicle (1% BSA), or volume (400 ul milliQ water) for 3 h.
Physiological FFA concentrations range from 250-500 uM, whereas pathophysiological concentrations can exceed 700 uM. After 3 hours, endothelium-dependent vasorelaxation and (45-min later) vascular smooth muscle function i.e., endothelium independent function, were assessed. tissue fluorescence is enhanced in sections treated with dibromide monohydrate i.e., a positive control; and results obtained using NIH Image J software (Bethesda, MD) could be confirmed using another software program i.e., Volocity (Lexington, MA). 8 In another cohort of mice that consumed HF and CON diets, NADPH oxidase enzyme activity was assessed in entire aortic segments. After the appropriate duration on the respective diets, mice were anesthetized, the chest was opened, and the aorta was dissected free of adherent tissue. Next, vessels were snap-frozen in liquid nitrogen, and stored until all arteries could be assayed on the same day. After pulverizing tissue using a cindered glass-to-glass instrument, tissue was homogenized in Krebs solution. 5uM N, N-dimethyl-9, 9-biacridinium dinitrate (lucigenin, Sigma, St. Louis, MO) was then added to the vessel homogenate in the presence or absence (buffer blank) of 100 uM NADPH while luminescence was measured every 1.8 s for 60 s. Enzyme activity (arbitrary units) was calculated as the sum value of luminescence during 60s.
Detection of vascular oxidant load.
Luminescence from the buffer blank was subtracted from values + 100 uM NADPH.
These values then were normalized initially for ug/L protein, and normalized finally to the Con group. Protein concentrations were determined using a commercially available BCA kit.
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Blood pressure. Mice were anesthetized using 2-5% isoflurane. Using aseptic techniques, the abdomen was opened and a transmitter probe (Data Sciences
International, St. Paul, MN) 12 was inserted and secured in place to allow ambulation with minimal hindrance. A catheter attached to the transmitter probe then was advanced subcutaneously and inserted into the right common carotid artery. Thirty second averages of blood pressure (systolic, diastolic, mean) and heart rate (HR) were recorded every 15-min, for three 24-hour periods, starting 6 days post surgery. Three 24-hour periods (i.e., days 7-9 post surgery) were averaged into one 24 hour period and used for data analysis.
13
Quantitative RT-PCR. Segments of aortae were isolated from adherent tissue and placed immediately in RNA-Later (200 µl, Ambion, Austin, TX), stored at 4°C overnight, frozen in liquid nitrogen, and transferred to -80°C until homogenized in 1 ml TRIzol reagent (Invitrogen, Carlsbad, CA). RNA was isolated using the RNeasy MINI RNA isolation kit (Qiagen, Valencia, CA). The resulting RNA concentration was determined by measuring the absorbance at 260 nm using a spectrophotometer. 13 Total RNA (~300 ng) then was reverse transcribed into cDNA using Superscript III (Invitrogen). The resulting cDNA was combined with Platinum Taq DNA polymerase (Invitrogen), primers, protein using the BCA protein assay kit (Thermo Scientific, Rockford, IL); 2) basal and insulin-stimulated p-Akt S473, p-Akt T308, p-ERK 1/2, p-eNOS S1177, and the respective total protein expression using immunoblotting procedures already described;
3) basal and insulin-stimulated NO production 14, 15 and 4) cell viability in response to all treatments. 16 p-eNOS to total eNOS was also assessed in BAECs incubated for 3 h in 500 µM palmitate or vehicle.
Nitrate/Nitrite [NO x ] in BAECs. BAECs were incubated with 500 µM palmitate or vehicle for 6 h. For the last hour, growth media was replaced and supplemented with media containing 10 µM arginine with or without 100 nM insulin to stimulate NO production. Preliminary time-course experiments (0 -90 min) indicated that 60-min was required to detect a robust increase in insulin-mediated NO production, and that this increase could be abolished by 100 mM L-NMMA (data not shown). 60-min after insulin or vehicle-treatment (i.e., at 6 h) 250 µL of cell media was obtained. NO that is produced in the media is rapidly oxidized to nitrite and then nitrate. When the nitratecontaining sample is combined with 0.5 M TRIS-HCl in the presence of a reducing wire, reduction of nitrate in the sample back to nitrite is facilitated. Nitrite then is reduced further to NO in an acidic iodide bath wherein it is detected by a commercially available amperometric sensor (amiNO 700 Innovative Technologies, Sarasota FL). 14, 15 The sensor detects the electric current that is generated as NO diffuses from the sample solution to the selectively permeable surface of the probe. The electric current generated is directly proportional to the concentration of NO in the sample. A calibration curve using 25, 50, and 100 nM of nitrite standard was generated before and after each experiment, and used to determine the concentration of NO produced by BAECs.
Cell Viability. To exclude the potential contribution from cell death to the effects of palmitate exposure, BAECs were cultured and treated as described. After the respective treatments, culture dishes were rinsed 5 x to remove dead (i.e., non-adherent) cells. WT, wild type mice; TTr-IR-/-, mice with genetic ablation of insulin receptors in all tissues except for brain, pancreas, and liver; Akt1-/-, mice with genetic ablation of the Akt1 isoform in all tissues; CON, mice that consumed standard rodent chow; HF, mice that consumed high-fat rodent chow.
